USPSTF 2023: Screening recommended for depression in adults, including in pregnant and postpartum persons (B recommendation)

Question clinique

Should primary care clinicians screen asymptomatic adults for depression and suicide risk?

L’Essentiel

The USPSTF continues to conclude that current evidence is sufficient to support an overall moderate net benefit in screening for depression in asymptomatic adults, 19 years or older, including pregnant and postpartum persons (B recommendation). However, see the discussion in the Synopsis regarding the high rate of false-positive screening results. The task force further concludes that current evidence is not sufficient to assess the balance of benefits and harms of screening for suicide risk in the same population (I statement). This updated review is consistent with the 2016 USPSTF recommendation statement. 2c

Plan de l'etude: Practice guideline

Financement: Government

Cadre: Various (guideline)

Reviewer

David C. Slawson, MD
Professor and Vice Chair of Family Medicine for Education and Scholarship
Atrium Health
Professor of Family Medicine, UNC Chapel Hill
Charlotte, NC


Discutez de ce POEM


Commentaires

DR ARUP KUMAR DHARA

Impact assessment

Excellent

Anonymous

Hard to recommend routine screening for depression and suici

What I thought before

Anonymous

Unrealistic to have GP do this. massively overwhelmed

Unrealistic to have GP do this. massively overwhelmed

Anonymous

SCRTEENIG IN DEPRESSED PREGNANT AND POSTPAURTUM PATIENTS

GOOD TO KNOW

Robert Wallace Shepherd

USPSTF 2023: Screening for depression recommended for adult

Since 75% of the positives are false positives, and the vast majority of true positives have mild depression which would not benefit from treatment, it seems that our time could be better spent on something other than screening for depression in adults.